Subtypes of Lung Cancer Tumors Identified
Posted on: Tuesday, 31 October 2006, 12:00 CST
A U.S. study has identified three subtypes of non-small-cell lung cancer tumors -- a finding that may provide information about patient survival.
University of North Carolina at Chapel Hill researchers say their discovery might have significant implications for people in the early or late stages of the disease, suggesting how likely the cancer is to spread and whether the tumor will prove resistant to chemotherapy.
Currently, lung cancer treatment decisions are based largely on the location and size of the tumor and if it has spread, or metastasized. Lung tumor cells are diagnosed by their appearance under a microscope.
About 20 percent of such tumors are classified as small-cell carcinomas; the rest fall into a catch-all diagnosis of "non-small-cell carcinoma, for which therapies often lead to unpredictable results.
While this is still very preliminary, we hope to take these gene expression patterns and attempt to define a very simple, reproducible system that will allow us to unravel the complex patterns of how the tumors progress and how they respond to therapy, said study lead author Dr. David Neil Hayes, assistant professor of medicine.
The study appears in the Journal of Clinical Oncology.
Source: United Press International
Related Articles
- New Notre Dame Study Provides Insights Into The Molecular Basis Of Tumor Cell Behavior
- Small Peptide Found To Stop Lung Cancer Tumor Growth In Mice
- Sleuths Study Lung Stem Cells For Generations To Shed Light On Healing
- Advalytix Announces Study of Single Circulating Tumor Cells With the M. D. Anderson Cancer Center
- Anavex 7-1037 Reduces Rate of Cancer Tumor Growth 69% in Pre-Clinical Studies, Compared to Currently Marketed Drug Dacarbazine Showing No Measurable Activity
- Immunicon Corporation Announces Independent Studies to Be Presented at 2007 San Antonio Breast Cancer Symposium That Confirm Utility of the CellSearch(TM) Circulating Tumor Cell Kit
- Biocept Announces Study to Isolate Circulating Tumor Cells From Blood
- CellSearch(TM) Circulating Tumor Cell Kit Receives FDA Clearance for Monitoring Patients With Metastatic Breast Cancer
- Immunicon Corporation Announces Presentation of Data on Circulating Tumor Cells in 'Non-Measurable' Metastatic Breast Cancer at the 2005 American Association of Clinical Oncology (ASCO) Annual Meeting
 |
 |
User Comments (0)
RSS Feeds